First-Time SBIR Applicants: 10 Mistakes That Get Proposals Rejected

Roughly 40% of SBIR Phase I proposals are rejected for reasons that have nothing to do with the quality of the underlying technology. Registration errors, budget mismatches, missing documentation, weak commercialization plans — these are the quiet killers. Reviewers see them in every cycle, and first-time applicants make them at three times the rate of experienced submitters.

The 2026 SBIR reauthorization extended the program through 2029 and added new compliance requirements around foreign risk screening. Agencies are expected to reopen solicitations in April and May 2026. If you are preparing your first submission, the window to fix these mistakes is now — before the clock starts.

1. Not Reading the Solicitation Carefully Enough

This sounds obvious. It is not. SBIR solicitations run 80 to 200 pages, and critical requirements are buried in sections most applicants skim. Page limits, font size mandates, required proposal sections, cost-sharing restrictions, and submission portal instructions vary by agency and sometimes by topic within the same solicitation.

A proposal that exceeds the page limit by two pages gets rejected without review at most agencies. A budget that includes cost-sharing when the solicitation prohibits it gets flagged. Read the entire solicitation — not just the topic description — before you start writing.

2. Writing Like an Academic Paper Instead of a Business Plan

SBIR is not a research grant. Every agency evaluates commercial potential alongside technical merit. NIH, NSF, DoD, and DOE all weight commercialization in their review criteria, and at NSF it carries equal weight with intellectual merit.

Proposals that read like journal articles — dense literature reviews, hypothesis-driven methodology, no mention of customers or revenue — consistently score poorly on the commercialization dimension. Lead with the problem you are solving for a paying customer. Describe the technical approach in service of that commercial goal.

3. Weak or Missing Commercialization Plan

At NIH, the commercialization plan is a separately scored section. At DoD, it is embedded in the evaluation criteria. At every agency, reviewers look for evidence that you have thought about who will buy this technology and how.

A commercialization plan that says "we will license our technology to industry partners" without naming a single partner, market segment, or revenue projection is effectively empty. Include market size data, identified customer segments, letters of intent if you have them, and a realistic timeline from Phase I results to first revenue.

4. Not Contacting the Program Manager or Topic Author

At DoD, every SBIR topic has a named Topic Author — the government scientist or engineer who wrote the requirement. At NIH, program officers manage specific areas and will discuss whether your concept fits. At NSF, program directors review Project Pitches personally.

These people want to hear from you before you submit. A 15-minute phone call can reveal whether your approach aligns with what the agency actually needs, whether the topic will be funded again, or whether your idea is better suited to a different solicitation. First-time applicants skip this step at their peril.

5. Budget That Doesn't Match the Work Plan

Reviewers are experienced enough to spot a budget that was assembled independently from the technical proposal. If your work plan describes three major experimental tasks but your budget allocates 80% of the funds to personnel on a single task, the disconnect is obvious.

Build the budget from the work plan. Each task should have corresponding labor hours, materials, and any subcontract costs. Phase I awards range from $50,000 to $275,000 depending on the agency — scope your work plan to fit the typical award size, not the other way around.

6. PI Not Primarily Employed by the Company

The SBIR program requires that the Principal Investigator be primarily employed by the small business at the time of award. "Primarily employed" means more than 50% of their time. A university professor who lists a startup as their SBIR company but remains full-time faculty does not meet this requirement.

This is a compliance issue, not a judgment call. Agencies verify employment status, and proposals that cannot demonstrate PI commitment get rejected. If you are transitioning from academia, document your employment arrangement clearly. For details on who qualifies under the 2026 rules, including the new foreign affiliation provisions, review the updated eligibility criteria.

7. Expired or Incomplete SAM.gov Registration

Every entity receiving federal funds must have an active registration in SAM.gov (System for Award Management). Registration takes 4-6 weeks for new entities, and existing registrations expire annually. An expired registration at the time of submission — or worse, at the time of award — can disqualify your proposal.

Check your SAM.gov status now. If you need to register, start immediately. You will also need a Unique Entity ID (UEI), which replaced the DUNS number. For a complete walkthrough of the SAM.gov registration and renewal process, including common pitfalls, see our dedicated guide.

8. Proposing Phase II Scope in a Phase I Proposal

Phase I exists to demonstrate feasibility. Phase II, which provides $500,000 to $1.75 million depending on the agency, is for full development. Reviewers know the difference, and a Phase I proposal that promises a finished prototype, clinical validation, or manufacturing scale-up is overscoped.

Define clear Phase I objectives that answer the question: "Is this technically feasible?" Save the development roadmap for the Phase II pitch. A well-scoped Phase I with achievable milestones signals maturity. An overscoped Phase I signals inexperience.

9. No Letters of Support or Customer Validation

Letters of support from potential customers, end users, or strategic partners serve two functions: they validate market demand, and they demonstrate that someone beyond the founding team believes in the technology. At NIH, letters from clinical partners or patient advocacy groups strengthen the commercialization narrative. At DoD, letters from prime contractors or program offices carry significant weight.

You do not need a signed purchase order. A letter stating that a company has evaluated your technology concept and would be interested in piloting it upon successful Phase I completion is sufficient. Three strong letters are better than none.

10. Ignoring Evaluation Criteria Weights

Every SBIR solicitation publishes its evaluation criteria and their relative weights. At NIH, Significance, Investigator(s), and Approach each carry specific weight within the scored review. At DoD, technical merit, qualifications, and commercial potential are weighted differently depending on the component.

Structure your proposal to match these weights. If technical merit is 40% of the score and commercialization is 30%, your proposal should dedicate proportional attention to each. First-time applicants often write proposals that are 90% technical and 10% everything else, then wonder why their scores suffer on non-technical criteria.

The Post-Reauthorization Addition: Foreign Risk Screening

The 2026 reauthorization introduced enhanced screening for foreign ownership, control, or influence (FOCI). Applicants will need to disclose foreign government connections, funding sources, and talent program participation. The SBA is developing implementation guidance expected by mid-2026.

If your company has foreign co-founders, foreign investors, or team members with active affiliations to foreign research institutions, prepare your disclosures now. Incomplete or inaccurate FOCI disclosures will be grounds for rejection — or worse, for award termination after funding.

Browse current SBIR opportunities across all agencies, review the complete application guide, and explore SBIR resources built for first-time applicants. Every mistake on this list is fixable before you submit — and Granted can help you catch them before a reviewer does.